Kidney cancer is one of the less frequently heard-about cancers, but its worldwide incidence is increasing. The lesser-known ...

Insulin resistance is now found in both Type 2 diabetes and Alzheimer's brains * Impaired glucose metabolism may drive early ...

Secondary forms of metabolic dysfunction-associated steatotic liver disease (MASLD) have different pathogeneses, ...

Thus, it is likely that many of the growth and atherosclerotic effects that have been attributed to insulin are mediated through an IGF-1 receptor either directly by IGF-1 or indirectly by high ...

The global surge in diabetes cases is a key factor propelling the artificial pancreas device market, as a larger patient base fuels the need for effe ...

We’re on track to develop the first-ever FDA-approved drug for longevity – for any species,” Celine Halioua told The Post.

They were designed to treat diabetes, then prescribed for weight loss, and now—as researchers are finding—they might hold the ...

The following is a summary of “Endocrine response in cardiogenic shock complicating myocardial infarction: the prognostic value of growth hormone and IGF-1,” published in the May 2025 issue of Journal ...

Growth hormone therapy improved exercise capacity, heart function, and quality of life in patients with HFrEF and growth ...

Viridian Therapeutics has a couple of milestones upcoming in 2025 and more pivotal once scheduled in 2026. Click here to find ...

Growth Hormone-Releasing Peptide-2 (GHRP-2) is a synthetic hexapeptide that has garnered significant attention in the scientific community for its unique properties and potential implications across ...

The Insulin Like Growth Factor I pipeline drugs market research report outlays comprehensive information on the Insulin Like Growth Factor I targeted therapeutics, complete with analysis by ...